ReviewActa pharmaceutica Sinica. B2020

Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives.

Yuan Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.